ATLASiShares U.S. Pharmaceuticals ETF (IHE): outlook, holdings and fees
iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund and is managed by iShares. The expense ratio is 0.41% and the yield is 1.45%. The ten largest holdings are 79% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on IHE
| Last price | $106.47 (-1.1%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 53% |
| Likely 1-month range (50%) | $103.04 – $110.87 |
| Normal 1-day range (±1σ) | ±1.2% |
| Distribution yield | 1.45% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
IHE fund facts
| Issuer | iShares |
|---|---|
| Theme | Healthcare |
| Assets under management | $1.6B |
| Expense ratio | 0.41% |
| Number of holdings | 53 |
| Portfolio turnover | 44% |
| Inception | May 1, 2006 |
| Exchange | NYSE |
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
IHE top holdings
| Holding | Sector | Weight |
|---|---|---|
| Eli Lilly and Company LLY | Healthcare | 23.04% |
| Johnson & Johnson JNJ | Healthcare | 23.07% |
| Zoetis Inc ZTS | Healthcare | 4.61% |
| Pfizer Inc PFE | Healthcare | 4.60% |
| Viatris Inc VTRS | Healthcare | 4.76% |
| Merck & Company Inc MRK | Healthcare | 4.39% |
| Royalty Pharma Plc RPRX | Healthcare | 4.47% |
| Bristol-Myers Squibb Company BMY | Healthcare | 4.40% |
| Jazz Pharmaceuticals PLC JAZZ | Healthcare | 3.28% |
| Corcept Therapeutics Incorporated CORT | Healthcare | 2.59% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
IHE sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 100.0%.
IHE returns and risk
| Year to date | +19.1% |
|---|---|
| 1 year | +39.2% |
| 3 years (annualised) | +20.1% |
| 5 years (annualised) | +12.9% |
| 10 years (annualised) | +9.3% |
| Volatility (3 years) | 15.9% |
| Sharpe ratio (3 years) | 1.09 |
Past returns do not guarantee future results.
IHE: frequently asked questions
What does IHE invest in?
iShares U.S. Pharmaceuticals ETF invests in a portfolio of securities. Its largest holdings are Eli Lilly and Company (23.0%), Johnson & Johnson (23.1%), Zoetis Inc (4.6%), Pfizer Inc (4.6%), Viatris Inc (4.8%).
What is the IHE expense ratio?
0.41% a year: about $41.00 for every $10,000 invested.
What is the IHE dividend yield?
1.45%. ATLAS does not hold the exact distribution dates for ETFs.
Will IHE go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 53%, with a likely range (50%) of $103.04 to $110.87 from $106.47 today. It is a probability, not a prediction.
How has IHE performed?
Year to date +19.1%, one year +39.2%, three years +20.1% a year, five years +12.9% a year. Past returns do not guarantee future results.
Similar ETFs: Healthcare
- State Street Health Care Select Sector SPDR ETF (XLV)
- Vanguard Health Care ETF (VHT)
- iShares Global Healthcare ETF (IXJ)
- iShares U.S. Healthcare ETF (IYH)
- iShares U.S. Medical Devices ETF (IHI)
- Fidelity MSCI Health Care Index ETF (FHLC)
- First Trust Health Care AlphaDEX Fund (FXH)
- First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Educational information, not investment advice. Disclaimer